Search

Your search keyword '"Kirkcaldy R"' showing total 19 results
Start Over Author "Kirkcaldy R"
19 results on '"Kirkcaldy R"'

1. O09.5 Characteristics of People with Gonorrhea with Reduced Azithromycin Antimicrobial Susceptibility in 8 Jurisdictions in the United States, 2018–2019

Author

Learner, E, primary, Gieseker, K, additional, Mauk, K, additional, Town, K, additional, Pham, C, additional, St Cyr, S, additional, Shrestha, D, additional, Barbee, L, additional, McNeil, C, additional, Holderman, J, additional, Johnson, K, additional, Nguyen, T, additional, Albano, T, additional, Schlanger, K, additional, and Kirkcaldy, R, additional

Published
2021
Full Text
View/download PDF

4. O08.4 Strengthening the U.S. Response to Resistant Gonorrhea (SURRG): A program to enhance local antibiotic resistant gonorrhea preparedness capacity

Author

Schlanger, K, primary, Mauk, K, additional, Learner, E, additional, Town, K, additional, Pham, C, additional, Bhattacharyya, S, additional, Sankaran, M, additional, Black, J, additional, Wendel, K, additional, McNeil, C, additional, Fukada, A, additional, Golden, M, additional, Schillinger, J, additional, and Kirkcaldy, R, additional

Published
2021
Full Text
View/download PDF

9. Extragenital Gonorrhea and Chlamydia Testing and Infection Among Men Who Have Sex With Men--STD Surveillance Network, United States, 2010-2012

Author

Patton, M. E., primary, Kidd, S., additional, Llata, E., additional, Stenger, M., additional, Braxton, J., additional, Asbel, L., additional, Bernstein, K., additional, Gratzer, B., additional, Jespersen, M., additional, Kerani, R., additional, Mettenbrink, C., additional, Mohamed, M., additional, Pathela, P., additional, Schumacher, C., additional, Stirland, A., additional, Stover, J., additional, Tabidze, I., additional, Kirkcaldy, R. D., additional, and Weinstock, H., additional

Published
2014
Full Text
View/download PDF

14. Neisseria gonorrhoeae With High-Level Resistance to Azithromycin: Case Report of the First Isolate Identified in the United States

Author

Katz, A. R., primary, Komeya, A. Y., additional, Soge, O. O., additional, Kiaha, M. I., additional, Lee, M. V. C., additional, Wasserman, G. M., additional, Maningas, E. V., additional, Whelen, A. C., additional, Kirkcaldy, R. D., additional, Shapiro, S. J., additional, Bolan, G. A., additional, and Holmes, K. K., additional

Published
2011
Full Text
View/download PDF

17. Congenital Syphilis -- United States, 2003-2008.

Author

Su, J. R., Berman, S. M., Davis, D., Weinstock, H. S., and Kirkcaldy, R. D.

Subjects
PUBLIC health surveillance, SYPHILIS, GENETIC disorders, NEONATAL diseases, AFRICAN American mothers
Abstract

The article presents a summary of the analysis made by the U.S. Centers for Disease Control and Prevention (CDC) regarding congenital syphilis (CS), using national surveillance data from 2003-2008. It was found that most of the increase in cases of CS rate occurred among infants born to African American mothers. According to the article, the increase in the CS incidence rate suggests an increase in the primary and secondary (P&S) syphilis rate among women in the U.S.

Published
2010

18. Healthy Vaccinee Bias and MenB-FHbp Vaccine Effectiveness Against Gonorrhea.

Author

Abara WE, Bernstein KT, Lewis FMT, Pathela P, Islam A, Eberhart M, Cheng I, Ternier A, Sanderson Slutsker J, Madera R, and Kirkcaldy R

Subjects
Humans, Vaccine Efficacy, Antigens, Bacterial, Gonorrhea epidemiology, Gonorrhea prevention & control, Neisseria meningitidis, Serogroup B, Meningococcal Vaccines
Abstract

Abstract: Observational studies demonstrated 30% to 40% effectiveness of outer-membrane vesicle (OMV) meningococcal serogroup B vaccines against gonorrhea. To explore whether healthy vaccinee bias influenced such findings, we examined the effectiveness of MenB-FHbp, a non-OMV vaccine that is not protective against gonorrhea. MenB-FHbp was ineffective against gonorrhea. Healthy vaccinee bias likely did not confound earlier studies of OMV vaccines., Competing Interests: Conflict of Interest and Sources of Funding: None declared., (Copyright © 2023 American Sexually Transmitted Diseases Association. All rights reserved.)

Published
2023
Full Text
View/download PDF

19. Tackling multidrug-resistant gonorrhea: how should we prepare for the untreatable?

Author

Kidd S, Kirkcaldy R, Weinstock H, and Bolan G

Subjects
Anti-Bacterial Agents pharmacology, Cefixime pharmacology, Ceftriaxone pharmacology, Gonorrhea epidemiology, Gonorrhea microbiology, Humans, Microbial Sensitivity Tests, Neisseria gonorrhoeae drug effects, Neisseria gonorrhoeae pathogenicity, Public Health legislation & jurisprudence, Treatment Failure, Drug Resistance, Multiple, Bacterial, Gonorrhea drug therapy
Published
2012
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results